General Information
Revision date
2018-12-20
Product name
Budesonide Inhalation Suspension
Manufacturer Name
The Ritedose Corporation
Icons in SDS
Company Information
company name
Lupin Pharmaceuticals, Inc
Section 2
SECTION 2: Hazards identification
Fire and Explosion Expected to be non-combustible. Health The use of budesonide inhalation suspension is contraindicated in the following conditions: Primary treatment of status asthmaticus or other acute episodes of asthma where intensive measures are required. Hypersensitivity to budesonide or any of the ingredients of budesonide inhalation suspension
Environmental hazards
No information is available about the potential of this product to produce
